Denali Therapeutics (NASDAQ:DNLI – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.06), MarketWatch Earnings reports. The firm had revenue of $42.10 million for the quarter, compared to analyst estimates of $33.32 million. Denali Therapeutics had a negative return […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Analysts predict that Denali Therapeutics Inc. (NASDAQ:DNLI – Get Rating) will post ($0.45) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Denali Therapeutics’ earnings. The lowest EPS estimate is ($0.66) and the highest is $0.04. Denali Therapeutics reported earnings per share of ($0.58) in […]
Denali Therapeutics Inc (NASDAQ:DNLI) CFO Sells $99,568 75 in Stock etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.